CM – ViiV is applying to the FDA for a version of the Triumeq HIV treatment for children

0

Keywords:

ViiV Healthcare Limited,HIV/AIDS,Food and Drug Administration,GlaxoSmithKline,Health care coverage and access,Dolutegravir,Pfizer,Abacavir / Dolutegravir / Lamivudine,ViiV Healthcare Limited, HIV/AIDS, Food and Drug Administration, GlaxoSmithKline, Health care coverage and access, Dolutegravir, Pfizer, Abacavir / Dolutegravir / Lamivudine,,

Donnez votre avis et abonnez-vous pour plus d’infos

Vidéo du jour: